These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 9609217

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW, Agnelli G.
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [Abstract] [Full Text] [Related]

  • 8. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C, Mouret P.
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Low molecular weight heparin versus unfractionated heparin in the treatment of deep venous thrombosis--a meta-analysis].
    Nielsen JD, Landorph A.
    Ugeskr Laeger; 1994 Oct 03; 156(40):5844-9. PubMed ID: 7985276
    [Abstract] [Full Text] [Related]

  • 13. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S, Breyer HG, Bacher HP, Fareed J, Misselwitz F, Victor N, Weber J, ECHOS Trial Group.
    Int Angiol; 2006 Dec 03; 25(4):335-42. PubMed ID: 17164738
    [Abstract] [Full Text] [Related]

  • 14. Rationale for low-molecular-weight heparin prophylaxis after total knee arthroplasty.
    Colwell CW, Hardwick ME.
    Clin Orthop Relat Res; 2006 Nov 03; 452():181-5. PubMed ID: 17016231
    [Abstract] [Full Text] [Related]

  • 15. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses.
    Koch A, Bouges S, Ziegler S, Dinkel H, Daures JP, Victor N.
    Br J Surg; 1997 Jun 03; 84(6):750-9. PubMed ID: 9189079
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement.
    O'Brien BJ, Anderson DR, Goeree R.
    CMAJ; 1994 Apr 01; 150(7):1083-90. PubMed ID: 8137188
    [Abstract] [Full Text] [Related]

  • 20. [Prevention of postoperative thrombosis with low-molecular-weight heparins].
    Jørgensen LN, Wille-Jørgensen PA, Hauch O.
    Ugeskr Laeger; 1994 Sep 26; 156(39):5667-72. PubMed ID: 7985248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.